CT Innovations leads $10M investment in Israeli medical device maker

Photo | VentureClash Officials from the companies who placed in Connecticut Innovations' 2018 VentureClash competition.

Write a Comment

By Matt Pilon

The state’s quasi-public venture capital arm Connecticut Innovations led a recent $10 million investment round for EyeControl, an Israel-based startup that makes a wearable device to help paralyzed and ventilated patients communicate through eye movements.

EyeControl tied for second place in CI’s fifth and final VentureClash competition last year.

The Series A round also included investments from Benslie International, Clive Barret and Menomadin Foundation, with participation from existing investors that included Benny Levin, Itsik Danziger, Jim Elkind, Avi Kornreich, Zora Ventures, Impact First and Rimonci Capital, the company said.

“With its innovative technology and bright team, we strongly believe this company will stand out and is well positioned for success,” said Matt Bloom, CI’s investment director and a member of the EyeControl board of directors.

EyeControl said the funding will help grow its activity within hospitals, where it is currently piloting its device to help ventilated COVID-19 patients communicate with nurses.

The company says its device is the first wearable, screenless assistive communication device.
CI said it invested $1 million of the total $10 million in the round.